Entrada Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 02/17/2026 | 5.07 M | $52.15 M | 4.25% | 12.23% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 4.06 M | $41.70 M | -4.70% | 9.78% |
| BLACKROCK, INC. | 02/12/2026 | 2.15 M | $22.07 M | 5.05% | 5.18% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 2.09 M | $21.47 M | 257.02% | 5.04% |
| VANGUARD GROUP INC | 01/29/2026 | 1.63 M | $16.78 M | 1.76% | 3.94% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 1.04 M | $10.74 M | 9.47% | 2.52% |
| STEPSTONE GROUP LP | 02/17/2026 | 761.28 K | $7.83 M | 0.00% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 639.95 K | $6.58 M | -0.80% | 1.54% |
| STATE STREET CORP | 02/13/2026 | 508.79 K | $5.23 M | 2.04% | 1.23% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 497.70 K | $5.12 M | -40.51% | 1.20% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 362.79 K | $3.73 M | 14.87% | 0.88% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 327.42 K | $3.37 M | -9.18% | 0.79% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 310.83 K | $3.19 M | 4.33% | 0.75% |
| CITADEL ADVISORS LLC | 02/17/2026 | 292.77 K | $3.01 M | -12.80% | 0.71% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 273.38 K | $2.81 M | -30.66% | 0.66% |
| MORGAN STANLEY | 02/13/2026 | 260.25 K | $2.68 M | -24.95% | 0.63% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 252.64 K | $2.60 M | -57.49% | 0.61% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 247.15 K | $2.54 M | -28.47% | 0.60% |
| NORTHERN TRUST CORP | 02/17/2026 | 226.30 K | $2.33 M | -10.77% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 221.27 K | $2.27 M | 19.44% | 0.53% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 205.17 K | $2.11 M | -7.72% | 0.49% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 180.97 K | $1.86 M | 22.10% | 0.44% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 176.02 K | $1.81 M | -38.86% | 0.42% |
| WOODLINE PARTNERS LP | 02/17/2026 | 142.11 K | $1.46 M | 100.00% | 0.34% |
| ALGERT GLOBAL LLC | 02/17/2026 | 128.61 K | $1.32 M | -0.93% | 0.31% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 121.28 K | $1.25 M | -1.29% | 0.29% |
| XTX TOPCO LTD | 02/17/2026 | 117.67 K | $1.21 M | 26.42% | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 110.94 K | $1.14 M | 100.00% | 0.27% |
| MOORE CAPITAL MANAGEMENT, LP | 02/17/2026 | 105.00 K | $1.08 M | 0.00% | 0.25% |
| JANE STREET GROUP, LLC | 02/12/2026 | 85.66 K | $880.61 K | -65.39% | 0.21% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 84.89 K | $872.70 K | 21.40% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 79.38 K | $815.98 K | -24.98% | 0.19% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 75.28 K | $773.90 K | -0.15% | 0.18% |
| JPMORGAN CHASE & CO | 02/11/2026 | 70.76 K | $727.42 K | -47.15% | 0.17% |
| QUANTINNO CAPITAL MANAGEMENT LP | 02/17/2026 | 67.72 K | $696.13 K | 16.29% | 0.16% |
| BARCLAYS PLC | 02/13/2026 | 67.15 K | $690.27 K | 10.75% | 0.16% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 66.88 K | $687.51 K | -6.53% | 0.16% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 65.98 K | $678.26 K | -47.82% | 0.16% |
| CANTOR FITZGERALD, L. P. | 02/17/2026 | 57.00 K | $585.96 K | -15.35% | 0.14% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 56.55 K | $572.32 K | -0.68% | 0.14% |
| NUVEEN, LLC | 02/12/2026 | 56.42 K | $579.96 K | 0.00% | 0.14% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/17/2026 | 51.69 K | $531.36 K | 100.00% | 0.12% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 49.30 K | $506.83 K | -47.10% | 0.12% |
| NAN FUNG GROUP HOLDINGS LTD | 02/13/2026 | 49.08 K | $504.56 K | 0.00% | 0.12% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 02/17/2026 | 47.97 K | $493.10 K | 100.00% | 0.12% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 45.95 K | $317.07 K | -11.76% | 0.11% |
| GREAT LAKES ADVISORS, LLC | 02/12/2026 | 43.27 K | $444.80 K | 5.46% | 0.10% |
| INVESCO LTD. | 02/19/2026 | 41.03 K | $421.82 K | 41.13% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 40.00 K | $411.20 K | 0.00% | 0.10% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 37.79 K | $388.46 K | 0.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Entrada Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 141 institutional investors and hedge funds held shares of Entrada Therapeutics Inc. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 211,689
Nuveen, LLC: 175,648
Bank of New York Mellon Corp: 76,427
HSBC HOLDINGS PLC: 38,137
UBS Group AG: 31,981
Allspring Global Investments Holdings, LLC: 19,465
58.92% of Entrada Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 31.21 M shares in the last 24 months. This purchase volume represents approximately $396.42 M in transactions.